An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non-Small Cell Lung Cancer: Validation Study Using

Weilin Meng1, Kelly M Mosesso2, Kathleen A Lane2

  • 1Center for Observational and Real-World Evidence, Merck & Co, Inc, Kenilworth, NJ, United States.

JMIR Medical Informatics
|October 12, 2021
PubMed
Summary

This study refined an algorithm for extracting line-of-therapy (LOT) data from electronic health records. The improved algorithm accurately identifies systemic anticancer therapy sequences, enhancing real-world data analysis.

Related Concept Videos